A carregar...
Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel
BACKGROUND: The luminal A subtype of breast cancer has a good prognosis and is sensitive to endocrine therapy but is less sensitive to chemotherapy. It is necessary to identify biomarkers to predict chemosensitivity and avoid over-treatment. We hypothesized that miRNAs in the serum might be associat...
Na minha lista:
Main Authors: | , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Public Library of Science
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4138038/ https://ncbi.nlm.nih.gov/pubmed/25137071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0104870 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|